| Application no. and date | 20789680.4 (espacenet) (Federated) (European Patent Register), 20200930 | | Patent/reg. no. and date | DK/EP 4038060, 20231115 | | Publication date | 20220810 | | Priority no. and date | US 201962911094 P, 20191004, US 202063074123 P, 20200903 | | EP pub. no. and date |
EP 4038060 20220810 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | | | Inventor | EDMONDS, David James, c/o Pfizer Inc. 610 Main Street
Cambridge, Massachusetts 02139, US,
FUTATSUGI, Kentaro, c/o Pfizer Inc. 610 Main Street
Cambridge, Massachusetts 02139, US,
FILIPSKI, Kevin James, c/o Pfizer Inc. 610 Main Street
Cambridge, Massachusetts 02139, US,
GARNSEY, Michelle Renee, c/o Pfizer Inc. 610 Main Street
Cambridge, Massachusetts 02139, US,
LEE, Jack Chang Hung, c/o Pfizer Inc. 445 Eastern Point Road
Groton, Connecticut 06340, US,
SMALTZ, Daniel Jonathan, c/o Pfizer Inc. 610 Main Street
Cambridge, Massachusetts 02139, US | | Representative | | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 3/00 (2006.01) , C07D 401/14 (2006.01) | | Title | DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR | | Int. application no. | IB2020059145 | | Int. publication no. | WO2021064590 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
